January 4, 2025 Top High-Yield Dividend Stocks To Watch For 2025
December 22, 2024 What About Federal Reserve Rates Cut?
December 20, 2024 Honda-Nissan Alliance: A Bold Move To Dominate Auto Industry
December 13, 2024 Trump’s Plan: Potential Shake-Up For Bank Regulators
Tesla: High Hopes, Low Deliveries
Nvidia: Don’t Expect Major Gains From Here (Technical Analysis)
3M Company: Laying The Groundwork For Margin Expansion
Pop Goes The Tesla (Our Top Short For 2025)
Apple: A Piece Of This Pie Is Too Expensive For Me
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
December 21, 2024 Best AI Trading & Performance Tools
December 21, 2024 Best Economic Calendars For Traders
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
Mirati Therapeutics (MRTX) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: January 16, 2025 (10:08)
Sector: HealthcareThe share price of Mirati Therapeutics, Inc. (MRTX) now
Are you interested in Mirati Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Mirati Therapeutics stock price in 2025, 2026, 2027. How much will one Mirati Therapeutics share be worth in 2025 - 2027?
When should I take profit in Mirati Therapeutics stock? When should I record a loss on Mirati Therapeutics stock? What are analysts' forecasts for Mirati Therapeutics stock? What is the future of Mirati Therapeutics stock? We forecast Mirati Therapeutics stock performance using neural networks based on historical data on Mirati Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Mirati Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Mirati Therapeutics shares. This happens once a day.
Historical and forecast chart of Mirati Therapeutics stock
The chart below shows the historical price of Mirati Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Mirati Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is focused on developing a pipeline of targeted cancer drugs. The company is developing candidate products to combat genetic and immunological cancer promoters. Its clinical programs consist of two candidate products: MRTX849, a Kirsten rat sarcoma inhibitor (KRAS) G12C, and Sitravatinib, a multi-kinase inhibitor. His KRAS inhibitor program is focused on the discovery and development of small molecule compounds that target KRAS G12C and G12D. MRTX849 is designed to inhibit the KRAS G12C mutations that are present in patients with non-small cell lung cancer (NSCLC), adenocarcinoma, colorectal cancer (CRC), pancreatic cancer, and several other intractable cancers. Sitravatinib is a spectrally selective kinase inhibitor designed to inhibit receptor tyrosine kinases (RTKs) including TAM family receptors (TYRO3, Axl, Mer), split family receptors (VEGFR2, KIT) and RET.
Mirati Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan 18 | 58.36 | 57.54 | 59.26 | 2.98 |
| Jan 19 | 58.31 | 57.54 | 58.98 | 2.49 |
| Jan 20 | 57.52 | 56.47 | 58.35 | 3.33 |
| Jan 21 | 56.06 | 54.80 | 57.10 | 4.20 |
| Jan 22 | 56.76 | 55.90 | 57.48 | 2.83 |
| Jan 23 | 57.48 | 56.39 | 58.53 | 3.79 |
| Jan 24 | 57.89 | 57.48 | 59.28 | 3.14 |
| Jan 25 | 57.03 | 56.51 | 58.38 | 3.30 |
| Jan 26 | 57.86 | 57.33 | 58.61 | 2.24 |
| Jan 27 | 58.38 | 58.02 | 58.98 | 1.66 |
| Jan 28 | 57.39 | 56.73 | 58.47 | 3.06 |
| Jan 29 | 57.08 | 56.63 | 58.10 | 2.60 |
| Jan 30 | 58.21 | 57.05 | 59.25 | 3.86 |
| Jan 31 | 58.87 | 57.56 | 59.40 | 3.19 |
| Feb 01 | 59.24 | 58.83 | 60.32 | 2.54 |
| Feb 02 | 60.86 | 59.45 | 61.77 | 3.90 |
| Feb 03 | 60.57 | 59.28 | 61.46 | 3.68 |
| Feb 04 | 59.86 | 59.17 | 61.10 | 3.25 |
| Feb 05 | 58.55 | 57.23 | 59.72 | 4.36 |
| Feb 06 | 56.95 | 56.61 | 58.06 | 2.57 |
| Feb 07 | 56.40 | 56.03 | 57.75 | 3.08 |
| Feb 08 | 54.88 | 54.55 | 56.16 | 2.96 |
| Feb 09 | 55.39 | 54.77 | 56.09 | 2.40 |
| Feb 10 | 55.87 | 55.00 | 56.47 | 2.68 |
| Feb 11 | 56.59 | 55.74 | 57.34 | 2.86 |
| Feb 12 | 57.85 | 57.40 | 59.24 | 3.21 |
| Feb 13 | 57.73 | 56.84 | 58.85 | 3.53 |
| Feb 14 | 58.42 | 57.45 | 59.33 | 3.26 |
| Feb 15 | 58.72 | 57.73 | 59.10 | 2.38 |
| Feb 16 | 58.31 | 56.98 | 59.15 | 3.81 |
Mirati Therapeutics Daily Price Targets
Mirati Therapeutics Stock Forecast 01-18-2025.
Forecast target price for 01-18-2025: $58.36.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.896%.
Pessimistic target level: 57.54
Optimistic target level: 59.26
Mirati Therapeutics Stock Forecast 01-19-2025.
Forecast target price for 01-19-2025: $58.31.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.432%.
Pessimistic target level: 57.54
Optimistic target level: 58.98
Mirati Therapeutics Stock Forecast 01-20-2025.
Forecast target price for 01-20-2025: $57.52.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.223%.
Pessimistic target level: 56.47
Optimistic target level: 58.35
Mirati Therapeutics Stock Forecast 01-21-2025.
Forecast target price for 01-21-2025: $56.06.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 4.035%.
Pessimistic target level: 54.80
Optimistic target level: 57.10
Mirati Therapeutics Stock Forecast 01-22-2025.
Forecast target price for 01-22-2025: $56.76.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.755%.
Pessimistic target level: 55.90
Optimistic target level: 57.48
Mirati Therapeutics Stock Forecast 01-23-2025.
Forecast target price for 01-23-2025: $57.48.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.653%.
Pessimistic target level: 56.39
Optimistic target level: 58.53
MRTX (MRTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb. | 59.76 | 52.85 | 65.94 | 19.85 |
| Mar. | 62.18 | 56.77 | 66.47 | 14.59 |
| Apr. | 59.94 | 53.55 | 62.10 | 13.75 |
| May. | 57.69 | 54.06 | 63.14 | 14.39 |
| Jun. | 50.68 | 47.64 | 54.18 | 12.07 |
| Jul. | 51.29 | 47.44 | 54.83 | 13.47 |
| Aug. | 52.29 | 50.49 | 54.72 | 7.74 |
| Sep. | 53.15 | 47.41 | 56.26 | 15.73 |
| Oct. | 50.28 | 46.06 | 55.94 | 17.66 |
| Nov. | 57.82 | 51.58 | 61.38 | 15.97 |
| Dec. | 60.34 | 57.72 | 65.23 | 11.52 |
Mirati Therapeutics forecast for this year
Mirati Therapeutics Stock Prediction for Feb 2025
An uptrend is forecast for this month with an optimal target price of $59.7566. Pessimistic: $52.85. Optimistic: $65.94
Mirati Therapeutics Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $62.1767. Pessimistic: $56.77. Optimistic: $66.47
Mirati Therapeutics Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $59.9384. Pessimistic: $53.55. Optimistic: $62.10
Mirati Therapeutics Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $57.6907. Pessimistic: $54.06. Optimistic: $63.14
Mirati Therapeutics Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $50.6813. Pessimistic: $47.64. Optimistic: $54.18
Mirati Therapeutics Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $51.2894. Pessimistic: $47.44. Optimistic: $54.83
Mirati Therapeutics Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $52.2896. Pessimistic: $50.49. Optimistic: $54.72
Mirati Therapeutics Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $53.1524. Pessimistic: $47.41. Optimistic: $56.26
Mirati Therapeutics Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $50.2821. Pessimistic: $46.06. Optimistic: $55.94
Mirati Therapeutics Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $57.8245. Pessimistic: $51.58. Optimistic: $61.38
Mirati Therapeutics Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $60.3398. Pessimistic: $57.72. Optimistic: $65.23
Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 59.80 | 53.61 | 63.47 | 15.54 |
| Feb | 64.91 | 61.31 | 72.21 | 15.10 |
| Mar | 73.77 | 70.67 | 80.74 | 12.47 |
| Apr | 80.85 | 73.57 | 83.76 | 12.16 |
| May | 75.03 | 66.48 | 79.42 | 16.30 |
| Jun | 76.04 | 68.51 | 82.09 | 16.54 |
| Jul | 70.80 | 62.41 | 74.09 | 15.77 |
| Aug | 71.96 | 65.27 | 78.44 | 16.79 |
| Sep | 62.25 | 55.15 | 67.01 | 17.70 |
| Oct | 64.30 | 56.88 | 70.86 | 19.74 |
| Nov | 60.35 | 53.38 | 63.52 | 15.96 |
| Dec | 62.25 | 55.99 | 64.58 | 13.30 |
Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 71.40 | 67.97 | 75.79 | 10.32 |
| Feb | 73.76 | 68.34 | 79.62 | 14.17 |
| Mar | 80.17 | 72.24 | 85.71 | 15.72 |
| Apr | 80.05 | 76.81 | 89.54 | 14.22 |
| May | 81.85 | 78.29 | 90.08 | 13.08 |
| Jun | 75.59 | 67.09 | 80.13 | 16.27 |
| Jul | 75.14 | 69.28 | 84.04 | 17.57 |
| Aug | 66.57 | 60.18 | 71.27 | 15.55 |
| Sep | 64.78 | 62.74 | 69.15 | 9.27 |
| Oct | 61.67 | 56.86 | 64.90 | 12.40 |
| Nov | 57.04 | 51.48 | 62.60 | 17.77 |
| Dec | 54.82 | 50.95 | 56.79 | 10.28 |
Mirati Therapeutics information and performance
N/A
Market capitalization of the Mirati Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MRTX shares in the company outstanding by the market price of one share.
EBITDA of Mirati Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
